Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

February 4 is observed as World Cancer Day. And one of the challenges men face is prostate cancer. Statistics show that, globally, approximately 1 in 8 men will be diagnosed with prostate cancer at ...

The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...

Investigators said the rise in advanced prostate cancer rates came after they stabilized or decreased between 2004 and 2010.

Duke University cancer researcher Prof Donald McDonnell on BTYSTE and how learning the scientific process at an early age is ...

A new UCSF study shows a significant increase in advanced prostate cancer cases in California, growing faster than the ...

A top UK doctor has been left ‘devastated’ after being diagnosed with an incurable cancer he’s spent his life treating.

Professor Adrian Crellin, 70, noticed blood in his urine and promptly sought medical attention from his GP, leading to a ...

Data highlights PYLARIFY’s ability to detect recurrent prostate cancer in patients with low PSAReal-world evidence of PYLARIFY’s effectiveness in ...

One of the UK's most senior radiotherapy experts has been diagnosed with incurable cancer - and said it was "bizarrely ...

Since the initial diagnosis, Prof Crellin has undergone chemotherapy and radiotherapy and continues to receive hormone ...

Professor Adrian Crellin, who was awarded a CBE for his work at the University of Leeds, has been diagnosed with the ...